key: cord-0858369-nyk4gzpl
authors: Li, Jianhui; Sun, Yi; Qin, Enqiang; Yuan, Hu; Liu, Mingbo; Yi, Wenqi; Chen, Zhu; Huang, Chengcheng; Zhou, Fengjie; Chen, Ruiyao; Zhang, Leibo; Yu, Ning; Liu, Qiong; Zhou, Xuejun; He, Jingjing; Li, Boyu; Wang, Fusheng; Yang, Changliang; Yang, Shiming
title: Olfactory and gustatory dysfunctions of COVID‐19 patients in China: A multicenter study
date: 2022-03-22
journal: World J Otorhinolaryngol Head Neck Surg
DOI: 10.1002/wjo2.5
sha: 78ab791d262ad7087285889fac9be49d8d4858fd
doc_id: 858369
cord_uid: nyk4gzpl

INTRODUCTION: With the spread of the epidemic worldwide, an increasing number of doctors abroad have observed the following atypical symptoms of coronavirus disease 2019 (COVID‐19): olfactory or taste disorders. Therefore, clarifying the incidence and clinical characteristics of olfactory and taste disorders in Chinese COVID‐19 patients is of great significance and urgency. MATERIALS AND METHODS: A retrospective study was conducted, which included 229 severe acute respiratory syndrome coronavirus 2 confirmed patients, through face‐to‐face interviews and telephone follow‐up. Following the completion of questionnaires, the patients participating in the study, were categorized according to the degree of olfactory and taste disorders experienced, and the proportion of each clinical type of patient with olfactory and taste disorders and the time when symptoms appeared were recorded. RESULTS: Among the 229 patients, 31 (13.54%) had olfactory dysfunction, and 44 (19.21%) had gustatory dysfunction. For the patients with olfactory dysfunction, 6 (19.35%) developed severe disease and became critically ill. Olfactory dysfunction appeared before the other symptoms in 21.43% of cases. The proportion of females with olfactory and gustatory dysfunction was higher than that of males (P < 0.001). CONCLUSIONS: The incidence of olfactory and gustatory dysfunction was much lower than that reported abroad; the prognosis of patients with olfactory dysfunction is relatively favorable; olfactory and gustatory dysfunction can be used as a sign for early screening; females are more prone to olfactory and gustatory dysfunction.

.

Of the 31 patients with olfactory dysfunctions, 21 (67.74%) were females, and 10 were males (32.26%). Of the 44 patients with gustatory dysfunction, 26 (59.09%) were females, and 18 were males (40.91%). Females were more likely to suffer from olfactory and gustatory dysfunction than males (P < 0.001).

COVID-19 is a novel infectious disease, and its pathogenesis and pathophysiology remain unclear. Studies have shown that coronavirus infection is associated with olfactory impairment, but the mechanism by which SARS-CoV-2 virus infection causes olfactory and gustatory dysfunctions is still unclear. 3, 4 The incidence of olfactory dysfunction and that of gustatory dysfunction in Chinese COVID-19 patients are 13.54% and 19.21%, respectively; these findings agree with other authors' reports from China but are much lower than the reported rates of 85.6% and 88.8% in foreign countries. 5, 6 The possible reason is that the virus has mutated during the transmission process, or there are different strains. Genetic and epidemiological data suggest that the D614G spike variant may be, in part, responsible for the increased frequency of chemosensory dysfunction during the current pandemic. 7 Different subtypes of viruses have different affinities and neurotoxicity to mucosal receptors in the olfactory and gustatory regions, resulting in differences in their biological behavior. 8 In addition, recent studies have shown that the expression of angiotensin-converting enzyme 2, the receptor of SARS-CoV-2, differs in populations and tissues. 7 Therefore, different populations have different susceptibilities to SARS-CoV-2 and different clinical manifestations. In addition, the outcomes are also different. 9 Among the patients with olfactory dysfunction, the proportion of patients who developed severe and critical illness was relatively small, that is, only 6 (19.35%) cases. This indicates that patients with olfactory dysfunction have a relatively good prognosis. The possible mechanism is that the virus in these patients is mainly concentrated in the upper airway, especially the nasal cavity and pharyngeal cavity.

Only a tiny amount of virus develops downward into the lower airway or other tissues and organs to cause-related clinical symptoms. 

Clinical features of patients infected with 2019 novel coronavirus in Wuhan

Smell and taste dysfunction in patients with COVID-19

Presentation of new onset anosmia during the COVID-19 pandemic

Pathophysiology of the COVID-19-entry to the CNS through the nose

Olfactory and gustatory dysfunctions as a clinical presentation of mild-tomoderate forms of the coronavirus disease (COVID-19): a multicenter European study

Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China

Chemosensory dysfunction in COVID-19: integration of genetic and epidemiological data points to D614G spike protein variant as a contributing factor

A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-toperson transmission: a study of a family cluster

Receptor and viral determinants of SARScoronavirus adaptation to human ACE2

Selfreported olfactory loss associates with outpatient clinical course in COVID-19

Features of anosmia in COVID-19

COVID-19 anosmia reporting tool: initial findings

The number of X chromosomes influences inflammatory cytokine production following Toll-like receptor stimulation

Reproductive status regulates expression of sex steroid and GnRH receptors in the olfactory bulb

Position paper on olfactory dysfunction

Electrophysiologic assessment of olfactory and gustatory function

What is the correlation between ratings and measures of olfactory function in patients with olfactory loss?

The combined olfactory test in a Chinese population

Olfactory and gustatory dysfunctions of COVID-19 patients in China: a multicenter study